otros

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

MarketWatch · 2026-08-05 16:52
📱 Ver más noticias en Prensly Leer la nota original ↗

Noticias relacionadas

Thora Ann SlaterEl-Sayed seeks to unite Democrats after bitter Michigan primaryMayor Says El-Sayed’s Win Shows He Is More Than a ‘Mini-Mamdani’El-Sayed’s Win in Michigan Sets Up the Left’s Biggest Test of the FallAfter Michigan Loss, AIPAC Weighs a Second Effort to Defeat El-SayedCivil rights group sues for bodycam footage of deadly Boston police shooting